The global nanomedicine market is projected to more than double over the next decade, rising to $554b by 2034 from $227b in ...

The chronic kidney disease (CKD) market in the seven major markets (7MM) reached $4.8b in 2024 and is projected to grow ...

The female technology market, valued at $6.9b in 2023, is estimated to reach $26.1b by 2033, expanding at a CAGR of 15.2% ...

The global smart inhalers market is set to reach $108.96b by 2034, according to a new report from Polaris Market Research.

The lipid nanoparticles (LNP) market is estimated to reach $3.1b by 2033, expanding at a compound annual growth rate of 13.1% from 2024 to 2033.

The global cardiac monitoring and cardiac rhythm management devices market is expected to grow from $27.90b in 2026 to ...

The global peripheral vascular devices market is on track for strong growth, projected to rise from $9.8b in 2024 to $15.5b ...

The global surgical equipment market is set to rise from $14.16b in 2025 to $27.40b by 2032, according to Maximize Market ...

The Albanese Government will invest $110 million over three years to prevent chronic conditions and improve care for Australians.

The global biliary tract cancer (BTC) market is growing steadily across the seven major markets (7MM)—the United States, EU4 ...